FindTrial
Sign In

Study on the Effect of Acupoint Massage Combined with Auricular Acupressure in Preventing and Treating Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Study on the Effect of Acupoint Massage Combined with Auricular Acupressure in Preventing and Treating Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001151
Enrollment
Unknown
Registered
2026-05-07
Start date
2025-09-30
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Interventions

Control Group:Received routine breast cancer chemotherapy care, health education, and follow-up
Intervention Group 1:Routine care + acupoint massage therapy
Intervention Group 2:Routine care + auricular acupressure therapy
Intervention Group 3:Routine care + combined acupoint massage and auricular acupressure

Sponsors

Tangshan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Inclusion criteria: 1) Inclusion criteria: (1. Age 18-75 years; (2. Female patients diagnosed with breast cancer by pathological examination; (3. Patients who have not previously received neurotoxic chemotherapy and are scheduled to receive albumin-bound paclitaxel 250 mg/m² for chemotherapy, with 21 days per cycle for a total of 4 cycles; (4. Karnofsky Performance Status Scale (KPS) score =60; (5. Expected survival period >9 months; (6. Clear consciousness, normal hearing, intact cognitive understanding ability, and able to cooperate in completing questionnaires; (7. Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: (2) Exclusion criteria: 1) Distant metastasis; 2) Severe organic diseases (cardiac, hepatic, cerebral, renal, etc.); 3) Pre-existing peripheral neuropathy from other causes (e.g., diabetes, peripheral nervous system disorders, inflammatory/metabolic arthritis); 4) Open wounds/herpes/ulcers on hands, feet, or auricle; 5) Latex/waterproof tape allergy; 6) Participation in other drug trials or external TCM therapies.

Design outcomes

Primary

MeasureTime frame
National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE v5.0);Baseline® Fold-UpTM Monofilament Evaluator, Set of 20 with Case;Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT);—

Secondary

MeasureTime frame
General Information Questionnaire;European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTCQL-C30);Grip Strength Test;Timed Up-and-Go (TUG) Test;Numerical Rating Scale (NRS);Traditional Chinese Medicine (TCM) Syndrome Efficacy Score;Pittsburgh Sleep Quality Index (PSQI);—

Countries

China

Contacts

Public ContactZhou Lizhi

Tangshan People's Hospital

zhoulizhi72@126.com13315563595

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026